Orchestra BioMed Holdings (OBIO) Profit After Tax: 2022-2025
Historic Profit After Tax for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to -$20.8 million.
- Orchestra BioMed Holdings' Profit After Tax fell 35.02% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 30.19%. This contributed to the annual value of -$61.0 million for FY2024, which is 24.23% down from last year.
- Per Orchestra BioMed Holdings' latest filing, its Profit After Tax stood at -$20.8 million for Q3 2025, which was down 7.57% from -$19.4 million recorded in Q2 2025.
- Orchestra BioMed Holdings' 5-year Profit After Tax high stood at -$5.7 million for Q1 2022, and its period low was -$20.8 million during Q3 2025.
- In the last 3 years, Orchestra BioMed Holdings' Profit After Tax had a median value of -$15.4 million in 2024 and averaged -$15.4 million.
- Data for Orchestra BioMed Holdings' Profit After Tax shows a maximum YoY plummeted of 90.96% (in 2023) over the last 5 years.
- Orchestra BioMed Holdings' Profit After Tax (Quarterly) stood at -$9.8 million in 2022, then tumbled by 31.47% to -$12.8 million in 2023, then declined by 26.03% to -$16.2 million in 2024, then tumbled by 35.02% to -$20.8 million in 2025.
- Its Profit After Tax stands at -$20.8 million for Q3 2025, versus -$19.4 million for Q2 2025 and -$18.8 million for Q1 2025.